U.S. Markets for Infection Control And Biosafety Products, April 2015

Each year, approximately two million hospital patients in the United States (U.S.) acquire a healthcare-associated infection, or HAI. The most common HAIs are those of the lungs, surgical site, and urinary tract. Approximately one-third of all HAIs are considered preventable.

This dynamic new report from Medtech Insight includes analyses of products, current/forecast markets, competitors, and opportunities in the U.S. market for infection control and biosafety products. Product areas covered by the scope of this report include nosocomial infection prevention products and services (e.g., medical waste disposal products and services, air filtration systems, indoor air quality monitoring systems, single-patient-use medical device reprocessing systems, and automated patient surveillance systems), injection devices and related products (e.g., skin puncture devices, non-skin puncture devices, and sharps disposal products), handwashes/perioperative skin preparations and disinfectants/germicides, and sterilization equipment, services, and supplies.

During the forecast period covered by this report, the combined U.S. market for infection control and biosafety products products is projected to increase from $10.8 billion in 2014 to $15.4 billion in the year 2019. Injection devices and related products account for more than half of sales in this market.